Commentary

Video

Adapting to the New Normal When a Loved One Has Cancer

Author(s):

Katie Couric discussed the many challenges she faced while being a caregiver to her husband during his nine-month battle with colorectal cancer and shared how her career helped her to cope with the loss and turmoil in her life.

When Katie Couric’s husband received a diagnosis of colorectal cancer, life was turned upside down for her family.

The legendary broadcast journalist sat down with CURE® to discuss the many challenges she faced while being caregiver to her husband during his nine-month battle and shared how her career helped her to cope with the turmoil in her life.

“My entire focus was on him and I remember I was still on ‘The Today Show’,” said Couric. “Those two hours felt like such a helpful escape because those were two hours in the day where I wasn’t focused on him, how he was doing, if he was going to get better, were there more treatments that I didn’t know about, was there a clinical trial he could enroll in … it was just all-encompassing and overwhelming.”

“After Jay died … I became two parents instead of one,” recalled Couric. “That was a huge responsibility and the new normal was just trying to get back to normal for my girls.”

Related Videos
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.